Related Experiment Videos
Molecular and clinical aspects of mitochondrial diabetes mellitus
J A Maassen1, E van Essen, J M van den Ouweland
1Department of Molecular Cell Biology, Leiden University Medical Centre, Leiden, The Netherlands. j.a.maassen@lumc.nl
Abstract:
This review provides a compact overview on the contribution of mutations in mtDNA to the pathogenesis of diabetes mellitus, with emphasis on the A3243G mutation in the tRNA(Leu, UUR) gene. This mutation associates in most individuals with maternally inherited diabetes and deafness (MIDD) whereas in some other carriers the MELAS syndrome or a progressive kidney failure is seen. Possible pathogenic mechanisms are discussed especially the question why particular mutations in mtDNA associate with distinct clinical entities. Mutations in mtDNA can affect the ATP production, thereby leading to particular clinical phenotypes such as muscle weakness. On the other hand mtDNA mutations may also alter the intracellular concentration of mitochondrial metabolites which can act as signalling molecules, such as Ca or glutamate. This situation may contribute to the development of particular phenotypes that are associated with distinct mtDNA mutations.
Insights
Mitochondrial DNA (mtDNA) mutations contribute to diabetes mellitus pathogenesis. The A3243G mutation in the tRNA(Leu, UUR) gene is linked to maternally inherited diabetes and deafness (MIDD), MELAS syndrome, or kidney failure.
Area of Science:
- Genetics
- Molecular Biology
- Endocrinology
Background:
- Mitochondrial DNA (mtDNA) mutations are implicated in various human diseases.
- The A3243G mutation in the tRNA(Leu, UUR) gene is a well-studied example with diverse clinical manifestations.
Purpose of the Study:
- To review the role of mtDNA mutations in the pathogenesis of diabetes mellitus.
- To explore the specific contribution of the A3243G mutation to distinct clinical phenotypes.
- To discuss potential pathogenic mechanisms underlying these associations.
Main Methods:
- Literature review of studies investigating mtDNA mutations and diabetes mellitus.
- Analysis of clinical data associated with the A3243G mutation.
- Discussion of proposed molecular mechanisms.
Main Results:
- The A3243G mutation is associated with maternally inherited diabetes and deafness (MIDD) in many individuals.
- Other carriers of the A3243G mutation may present with MELAS syndrome or progressive kidney failure.
- mtDNA mutations can impair ATP production, leading to phenotypes like muscle weakness.
- mtDNA mutations can alter mitochondrial metabolite concentrations, affecting signaling pathways (e.g., Ca2+, glutamate).
Conclusions:
- mtDNA mutations play a significant role in the pathogenesis of diabetes mellitus and related disorders.
- The specific clinical phenotype associated with an mtDNA mutation may depend on its impact on cellular energy production and signaling.
- Further research is needed to fully elucidate the complex genotype-phenotype relationships in mtDNA-related diseases.